Peripheral Artery Disease study: Wearable activities monitor
Official title Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers
ClinicalTrials.gov ID: NCT07012070
What this study is testing
- What it's testing
- This study wants to find out if doing walking exercises at home with a wearable tracker and app is just as effective as going to a clinic for supervised exercise.
- Who it's for
- The study is looking for people who have Peripheral Artery Disease (narrowed arteries in the legs) and experience pain when walking.
- What's involved
- Participants will be assigned to either do supervised exercise at a clinic or do self-guided walking at home using a wearable activity tracker and a mobile app that gives automatic feedback.
- Time commitment
- The source text does not specify the total duration of the study or the number of required visits.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients who are newly diagnosed with symptomatic claudication as defined by the presence of claudication symptoms elicited by the single...
- Patients who ABI \<0.9 are the primary target population
You likely can't join if
- Patients is inability to ambulate without walking aids or understand the instruction of exercise
- Patients have history of previous percutaneous or surgical revascularization of lower limb
- Patients is presence of critical limb ischemia or gangrene
- Patients has history of major amputation of the lower limb
- Patients is presence of other co-morbidities which limit walking ability
- Patients is presence of cardiovascular instability which includes unstable angina or acute coronary syndrome
See the full eligibility criteria
- Patients who are newly diagnosed with symptomatic claudication as defined by the presence of claudication symptoms elicited by the single claudication question
- Patients who ABI \<0.9 are the primary target population
- Patients is inability to ambulate without walking aids or understand the instruction of exercise
- Patients have history of previous percutaneous or surgical revascularization of lower limb
- Patients is presence of critical limb ischemia or gangrene
- Patients has history of major amputation of the lower limb
- Patients is presence of other co-morbidities which limit walking ability
- Patients is presence of cardiovascular instability which includes unstable angina or acute coronary syndrome
- Patients diagnosed active class III/IV heart failure
- Patients is inability to operate simple electronic devices
- Patients is inaccessibility of a mobile network service in the place of residence
- Patients is unwillingness in sharing individual data to study team
- Patients is life-expectance less than 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Hong Kong, Hong Kong, Hong Kong
- Hong Kong, Shatin, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hong Kong, Hong Kong, Hong Kong; Hong Kong, Shatin, Hong Kong. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.